Alpha

Archives
Subscribe
December 4, 2025

Alpha Signal Monitor - Daily Market Briefing | December 04, 2025

Daily Market Research Report

December 04, 2025

Alpha Signal Monitor

Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.

Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts

Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM


This report is generated using advanced AI research capabilities with real-time market data access.


Institutional Outlook on Gold ETFs — as of December 4, 2025

Trading Idea: Buy Rationale (TL;DR): Consensus across major houses is for higher gold into 2026 on strong central-bank buying, resurgent ETF inflows and an approaching Fed easing cycle; most forecasts cluster around $4,400–$5,000/oz by 2026, supportive for GLD/IAU/BAR over the next 6–18 months.

Late‑2025 backdrop: gold remains volatile but elevated, with traders focused on an anticipated Fed rate cut and softer U.S. growth data; this macro mix continues to favor non‑yielding hedges. Strategists highlight persistent official‑sector demand (near ~1,000t p.a. in some house views) and a reversal toward positive ETF flows as key supports alongside policy/geopolitical uncertainty and tariff risks.

Key Drivers - Central bank accumulation staying robust and potentially rising in 2026. - Re‑acceleration of gold‑backed ETF inflows as rates fall and hedge demand rises. - Fed easing cycle and potential USD/real‑yield declines. - Policy/geopolitical uncertainty (tariffs, fiscal deficits, questions around Fed independence) sustaining safe‑haven bids. - Limited mine supply responsiveness near‑term; constrained capex cycle for producers.

Institution Stance Price View Key Evidence Last Update Source
Goldman Sachs Bullish $4,000/oz by mid‑2026; prior YE2025 range/target revisions included $3,300. GS cites structural central‑bank demand and Fed easing that should lift ETF flows; maintained a constructive path to $4,000 by mid‑2026 after earlier 2025 upgrades. 2025-09-30 Goldman Sachs Insights (Sep 30, 2025); press coverage of Mar 27, 2025 forecast lift (Investing.com).
Morgan Stanley Positive $4,500/oz by mid‑2026; MS Research raised 2026 avg to ~$4,400/oz (Oct 2025). MS expects further upside on falling USD, strong ETF buying and continued central‑bank purchases; notes overbought risks and some jewelry demand softness. 2025-10-31 Morgan Stanley Insights (Oct 22, 2025); Reuters summary via TradingView (Oct 31, 2025).
JP Morgan Overweight / “Highest‑conviction long” ~$3,675/oz in 4Q25 (avg); ~$5,055/oz by 4Q26 (avg). JPM argues a structural bull case with gold as an optimal hedge for stagflation, debasement and policy risks; sees upside as Fed enters a cutting cycle. 2025-10-23 J.P. Morgan Research (Jun 10, 2025) and Reuters note (Oct 23, 2025).
Bank of America Bullish Path to $5,000/oz in 2026; ~$4,400/oz 2026 average in base case. BofA lifted its 2026 outlook, citing rising investment demand, fiscal deficits/debasement risk and supportive policy; acknowledges near‑term correction risk. 2025-10-13 Reuters (BofA raises 2026 gold outlook to $5,000).
Citigroup Neutral (near‑term); Buy‑the‑dip bias earlier in 2025 0–3 month target cut to $3,800/oz (Oct 28, 2025). Citi trimmed short‑term targets on improved macro momentum and fading shutdown risk, after earlier hikes tied to China insurer demand and tariff risks. 2025-10-28 Reuters factboxes (Oct 28, 2025; Apr 17, 2025).
UBS (Chief Investment Office) Most Preferred / Attractive Raised mid‑2026 target to ~$4,500/oz; earlier YE2025 ~$3,800 and mid‑2026 ~$3,900 (other UBS publications). UBS CIO remains overweight gold as a portfolio hedge, citing structural central‑bank accumulation, policy/geopolitical risks and improving ETF flows; recommends mid‑single‑digit allocations. - UBS CIO House View weekly key messages (2025); UBS CIO note (Apr 11, 2025); Reuters (Sep 12, 2025).
HSBC Bullish 2025 avg ~$3,455/oz; 2026 avg ~$4,600/oz with potential to reach $5,000 in 2026. HSBC highlights a sustained ‘bull wave’ driven by geopolitics, public debt and sticky official/institutional demand; Fed cuts supportive early in the cycle. 2025-10-17 Reuters (Oct 17, 2025 updates).
Deutsche Bank Bullish 2026 avg ~$4,450/oz (range $3,950–$4,950); earlier $4,000/oz (Sep 2025). DB cites stabilizing flows, persistent central‑bank/ETF demand and a ~$3,900 floor; sees upside skew with supportive FX/rates backdrops. 2025-11-26 Reuters (Nov 26, 2025; Sep 17, 2025).

Risk Considerations - Hawkish Fed path, stronger USD or higher real yields that pressure non‑yielding assets. - A slowdown in official‑sector purchases or outright reserve selling. - ETF outflows if risk appetite returns or volatility triggers de‑risking. - Demand destruction on high prices (e.g., jewelry) or rapid mean‑reversion after overbought conditions. - Diminishing geopolitical/policy risks (trade truces, fiscal consolidation) reducing hedge demand.

Position GLD/IAU/BAR as core hedges with a 6–18 month horizon. Given broad sell‑side upside to 2026 and improving ETF flow dynamics, buy pullbacks and scale in; reassess sizing if real yields or USD trend materially higher, or if official‑sector demand softens.


Stock Ratings — Street targets and ratings from GS, MS, JPM, BAC, C, WFC for selected mega-cap tech names (as of Dec 4, 2025)

Below are the most recent price targets/ratings we could verify from the specified six institutions. Targets are shown in USD unless noted; “Overweight/Outperform” mapped to Buy, “Equal Weight/Neutral” to Hold, and “Underweight” to Sell.

AAPL - Apple Inc.

Most banks remain Buy/Overweight; BAC’s October raise is the latest among the six.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $266 Sep 16, 2025 Reiterate Buy on stronger iPhone 17 demand/lead-times. https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-buy-rating-on-apple-stock-citing-strong-iphone-17-demand-93CH-4239936
Morgan Stanley Buy $235 Jun 5, 2025 Overweight maintained; App Store growth supports view. https://www.investing.com/news/analyst-ratings/morgan-stanley-maintains-apple-stock-target-amid-app-store-growth-4082375
JP Morgan Buy $240 Jun 3, 2025 Overweight reiterated into WWDC. https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-apple-stock-rating-with-240-price-target-4077532
Bank of America Buy $320 Oct 29, 2025 Raised PT on longer-term framework and higher out-year EPS. https://www.investing.com/news/stock-market-news/apple-stock-target-raised-at-bofa-after-new-5year-outlook-analysis-4316591
Citigroup Buy $240 Jul 11, 2025 Reiterate Buy; modest unit forecast tweaks. https://www.investing.com/news/analyst-ratings/citi-maintains-apple-stock-buy-rating-with-240-target-amid-iphone-demand-shifts-93CH-4131765
Wells Fargo Buy $290 Oct 21, 2025 Overweight; PT lifted from prior $245 in August. https://www.gurufocus.com/news/3152412/aapl-wells-fargo-raises-price-target-to-290-maintains-overweight-rating-aapl-stock-news

Consensus View - Rating: Buy, Target Price: $265 - 6/6 positive (Buy/Overweight) with average target near mid-$260s.

MSFT - Microsoft Corp.

Strongest upside from WFC/Citi; widespread Buy/OW on Azure/AI momentum.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $500 Feb 24, 2025 Maintain Buy; AI/CapEx visibility. https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-500-target-on-microsoft-stock-bullish-on-ai-3887616
Morgan Stanley Buy $625 Sep 26, 2025 Top Pick in large-cap software. https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-625-from-582-at-morgan-stanley-93CH-4256920
JP Morgan Buy $475 May 1, 2025 Overweight; post-FQ3 beat. https://www.investing.com/news/analyst-ratings/jpmorgan-raises-microsoft-stock-price-target-to-475-4015871
Bank of America Buy $585 Jul 18, 2025 Raise PT into FQ4 on Azure strength/Copilot traction. https://www.investing.com/news/analyst-ratings/bofa-securities-raises-microsoft-stock-price-target-to-585-on-azure-strength-93CH-4142222
Citigroup Buy $690 Oct 30, 2025 Buy maintained; PT increased. https://www.gurufocus.com/news/3172856/msft-sees-price-target-increase-to-690-by-citigroup-maintaining-buy-rating-msft-stock-news
Wells Fargo Buy $700 Oct 30, 2025 Overweight; Azure momentum and bookings. https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-700-from-675-at-wells-fargo-93CH-4318741

Consensus View - Rating: Buy, Target Price: $596 - All six positive; consensus near $600.

GOOGL - Alphabet Inc.

Five positive calls vs. WFC at Hold; GS/MS lifted targets post Q3’25.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $330 Oct 30, 2025 Raised PT on strong Search/YouTube and Cloud. https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-alphabet-stock-price-target-to-330-on-strong-cloud-growth-93CH-4317850
Morgan Stanley Buy $330 Oct 30, 2025 Overweight; PT raised from $270. https://www.gurufocus.com/news/3172847/googl-morgan-stanley-raises-price-target-amid-overweight-rating-googl-stock-news
JP Morgan Buy $195 May 21, 2025 Overweight post Google I/O. https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-alphabet-stock-with-195-target-post-google-io-93CH-4056279
Bank of America Buy $335 Oct 30, 2025 PT raised after Q3 beat. https://www.marketbeat.com/instant-alerts/alphabet-nasdaqgoogl-price-target-raised-to-33500-2025-10-30/
Citigroup Buy $200 May 21, 2025 Buy reiterated alongside AI product updates. https://www.investing.com/news/analyst-ratings/citi-maintains-buy-rating-and-200-target-on-alphabet-stock-4056278
Wells Fargo Hold $268 Oct 30, 2025 Equal Weight; PT raised from $236. https://www.gurufocus.com/news/3171027/googl-wells-fargo-raises-alphabets-price-target-to-268-googl-stock-news

Consensus View - Rating: Buy, Target Price: $276 - Broad Buy/OW skew; one Hold (WFC).

AMZN - Amazon.com Inc.

Banks broadly constructive on AWS reacceleration and margin expansion.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $290 Oct 31, 2025 Raise PT; multi-year revenue and margin story. https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-amazon-stock-raises-price-target-93CH-4322387
Morgan Stanley Buy $250 May 2, 2025 Overweight maintained. https://www.investing.com/news/analyst-ratings/morgan-stanley-maintains-amazon-stock-overweight-rating-250-target-4018899
JP Morgan Buy $255 Jul 11, 2025 Overweight into Q2 preview. https://www.gurufocus.com/news/2971607/jpmorgan-increases-price-target-for-amazon-amzn-to-255--amzn-stock-news
Bank of America Buy $272 Aug 1, 2025 PT raised post-earnings; retail strength. https://www.investing.com/news/analyst-ratings/amazon-stock-price-target-raised-to-272-by-bofa-on-strong-retail-growth-93CH-4165296
Citigroup Buy $265 Jul 22, 2025 PT raised on AWS growth outlook. https://www.investing.com/news/analyst-ratings/citi-raises-amazon-stock-price-target-to-265-on-aws-growth-outlook-4145282
Wells Fargo Buy $295 Dec 2, 2025 Overweight; target raised from $292. https://www.gurufocus.com/news/3230110/amazoncom-amzn-wells-fargo-raises-price-target-to-295-amzn-stock-news

Consensus View - Rating: Buy, Target Price: $271 - All six positive; average target low-$270s.

NVDA - NVIDIA Corp.

Latest round of raises into/after late-2025 prints; all six positive/OW.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $250 Nov 20, 2025 Raised PT post results; Rubin on-track mid-2026. https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-nvidia-stock-price-target-to-250-on-ai-outlook-93CH-4369369
Morgan Stanley Buy $250 Dec 2025 Overweight; PT raised from $235 to $250. https://www.businessinsider.com/nvidia-stock-price-prediction-bullish-outlook-ai-chip-revenue-asia-2025-12
JP Morgan Buy $250 Nov 20, 2025 Overweight; PT lifted from $215. https://www.marketbeat.com/instant-alerts/nvidia-nasdaqnvda-price-target-raised-to-25000-at-jpmorgan-chase-co-2025-11-20/
Bank of America Buy $275 Oct 29, 2025 Buy; PT raised (from $235). https://www.gurufocus.com/news/3178597/goldman-sachs-raises-price-target-for-nvda-to-240-nvda-stock-news
Citigroup Buy $163 Mar 12, 2025 Buy maintained into GTC/Blackwell. https://www.investing.com/news/analyst-ratings/citi-maintains-nvidia-stock-buy-rating-163-target-3923024
Wells Fargo Buy $265 Nov 14, 2025 Overweight; PT raised on hyperscale DC momentum. https://www.investing.com/news/analyst-ratings/wells-fargo-raises-nvidia-stock-price-target-to-265-on-ai-growth-outlook-93CH-4359275

Consensus View - Rating: Buy, Target Price: $242 - Six Buys/OW; average around mid-$240s.

META - Meta Platforms Inc.

Universally positive across the six; multiple PT hikes through 2H25.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $815 Oct 30, 2025 PT trimmed but Buy maintained post Q3. https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-meta-stock-price-target-to-815-on-investment-cycle-93CH-4317852
Morgan Stanley Buy $650 May 1, 2025 Overweight; PT raised to $650. https://www.investing.com/news/analyst-ratings/morgan-stanley-lifts-meta-stock-price-target-to-650-4015638
JP Morgan Buy $875 Jul 31, 2025 Overweight; raised from $795. https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-875-from-795-at-jpmorgan-4163780
Bank of America Buy $900 Jul 31, 2025 PT raised on higher growth/AI optionality. https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-900-from-775-at-bofa-93CH-4161928
Citigroup Buy $915 Sep 18, 2025 Buy reiterated after Connect; AI devices path. https://www.investing.com/news/analyst-ratings/citi-reiterates-buy-rating-on-meta-stock-maintains-915-price-target-93CH-4244395
Wells Fargo Buy $837 Oct 7, 2025 Overweight; PT raised from $811. https://www.gurufocus.com/news/3133898/wells-fargo-raises-meta-platforms-meta-price-target-to-837-meta-stock-news

Consensus View - Rating: Buy, Target Price: $832 - All six positive; average low-$830s.

TSLA - Tesla Inc.

Views are split; MS remains bullish while JPM/WFC are negative and GS/BAC/Citi sit Neutral/Hold.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Hold $400 Oct 23, 2025 Neutral reiterated post Q3. https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-tesla-stock-at-neutral-with-400-price-target-93CH-4303708
Morgan Stanley Buy $430 Mar 12, 2025 Overweight; firm’s US autos Top Pick in 2025. https://www.investing.com/news/analyst-ratings/morgan-stanley-maintains-tesla-stock-overweight-rating-430-target-93CH-3924182
JP Morgan Sell $115 Jul 1, 2025 Underweight maintained on demand/deliveries concerns. https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-tesla-stock-underweight-rating-amid-delivery-concerns-4118615
Bank of America Hold $471 Oct 29, 2025 Downgraded to Neutral earlier in 2025; PT subsequently raised. https://price-target.com/2025/10/29/164190
Citigroup Hold $196 - Neutral; PT lowered ahead of Q1 deliveries (TheFly/TipRanks). https://www.tipranks.com/news/the-fly/tesla-price-target-lowered-to-196-from-224-at-citi
Wells Fargo Sell $120 Oct 23, 2025 Underweight maintained after EPS miss; bearish on margins. https://www.investing.com/news/analyst-ratings/wells-fargo-reiterates-underweight-rating-on-tesla-stock-after-eps-miss-93CH-4303537

Consensus View - Rating: Hold, Target Price: $289 - Blend of 1 Buy, 3 Holds, 2 Sells; average target high-$280s.

AVGO - Broadcom Inc. (AVGO)

All positive or neutral-to-positive; multiple raises on custom AI/XPU strength.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy $315 Jul 10, 2025 Initiated/maintained Buy on infra software + custom silicon mix. https://www.investing.com/news/analyst-ratings/goldman-sachs-initiates-broadcom-stock-with-buy-rating-315-target-93CH-4129499
Morgan Stanley Buy $357 Sep 2, 2025 Overweight; PT raised on AI momentum. https://www.gurufocus.com/news/3090384/avgo-morgan-stanley-raises-price-target-to-357-while-maintaining-overweight-rating-avgo-stock-news
JP Morgan Buy $400 Sep 5, 2025 Overweight; AVGO a tech infra powerhouse. https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521
Bank of America Buy $400 Sep 5, 2025 Top pick; accelerated custom AI chip growth. https://www.investing.com/news/analyst-ratings/bofa-securities-raises-broadcom-stock-price-target-to-400-on-ai-growth-93CH-4226065
Citigroup Buy $285 Jun 6, 2025 PT lifted on AI mix. https://www.investing.com/news/analyst-ratings/citi-raises-broadcom-stock-price-target-to-285-on-ai-growth-93CH-4084758
Wells Fargo Hold $345 Sep 5, 2025 Equal-Weight; PT raised from $255. https://www.ainvest.com/news/broadcom-wells-fargo-maintains-equal-weight-rating-target-price-345-2509/

Consensus View - Rating: Buy, Target Price: $350 - Five positive, one Hold; avg target about $350.

TSM - Taiwan Semiconductor Manufacturing Co. Ltd. (TSMC)

Consensus very constructive across five banks; WFC not found/NA.

Institution Rating Target Price Last Update Notes Source
Goldman Sachs Buy NT$1,400 Jan 17, 2025 Raised long-term CAGR on AI; PT to NT$1,400. https://www.investing.com/news/stock-market-news/goldman-sachs-boosts-tsmc-pt-to-nt1400-on-ai-growth-outlook-3818781
Morgan Stanley Buy NT$1,588 Sep 30, 2025 Overweight; Street-high PT raised on AI demand/pricing. https://finance.yahoo.com/news/tsmc-stock-target-raised-morgan-121223698.html
JP Morgan Buy NT$1,500 Mar 5, 2025 Overweight reiterated. https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-tsmc-stock-overweight-twd1500-target-93CH-3908014
Bank of America Buy NT$1,600 Oct 7, 2025 PT raised on improved pricing/visibility. https://www.investing.com/news/stock-market-news/bofa-raises-tsmc-target-sees-improved-pricing-outlook-4275321
Citigroup Buy NT$1,400 Jul 17, 2025 PT raised after strong Q2’25. https://www.investing.com/news/analyst-ratings/tsmc-stock-price-target-raised-to-nt1400-by-citi-on-strong-2q25-results-4140181
Wells Fargo - - - No recent, attributable rating/target found from WFC. -

Consensus View - Rating: Buy, Target Price: NT$1,498 - Average of five banks with targets; uniformly Buy/OW.

Highlights

  • Buy/Overweight consensus across AAPL, MSFT, AMZN, NVDA, META, AVGO, TSM; only TSLA is mixed with a Hold consensus.
  • Highest single-bank upside targets among the set: MSFT (WFC $700; Citi $690), META (BAC $900; JPM $875).
  • TSM targets are quoted in TWD and cluster around NT$1.5T; WFC coverage not found in recent period.

Notes: Dates reflect the most recent article/report we could verify for each institution. Ratings language normalized (Overweight=Buy; Equal Weight/Neutral=Hold; Underweight=Sell). Targets and sources are institution-specific and may differ from broader ‘Street’ consensus providers.


IPO Calendar

Timeframe: December 4, 2025 to January 4, 2026 (US equity markets)

The final U.S. IPO window of 2025 is concentrated in the two trading weeks beginning December 8 and December 15, with bookbuilds launching as the SEC works through a post‑shutdown backlog. Expect a mix of private‑equity–backed services (healthcare imaging, construction/infrastructure), fintech, space/defense hardware, and crypto‑adjacent asset management. Several large on‑file issuers could still launch before year‑end, though some may slip into early 2026 depending on market tone and SEC effectiveness timelines.

Lumexa Imaging Holdings, Inc. (LMRI)

  • Expected listing date: Week of December 8, 2025 (pricing TBA)
  • Price range: $17.00–$20.00 per share
  • Shares offered: 25,000,000 primary shares (+ 3,750,000 overallotment option)
  • Exchange: Nasdaq Global Market
  • Lead underwriters: Barclays, J.P. Morgan, Jefferies, Deutsche Bank Securities, Wells Fargo Securities, Leerink Partners, William Blair, Capital One Securities, Fifth Third Securities, Raymond James, PNC Capital Markets
  • Business summary: National outpatient diagnostic imaging provider operating 184 centers across 13 U.S. states (MRI, CT, PET, X‑ray, ultrasound, mammography). Formed in 2018 by Charlotte Radiology and WCAS; growth via acquisitions and de novo centers.
  • Notes: Company launched the IPO on Dec 2 with terms; targeted fully diluted market value ~ $1.8–$1.9B at range. Expected to price during the week of Dec 8, subject to market conditions and SEC effectiveness.
  • Sources: https://www.prnewswire.com/news-releases/lumexa-imaging-announces-launch-of-initial-public-offering-302630316.html, https://www.reuters.com/business/healthcare-pharmaceuticals/lumexa-imaging-targets-up-189-billion-valuation-us-ipo-2025-12-02/, https://www.renaissancecapital.com/IPO-Center/News/115272/Outpatient-radiology-network-Lumexa-Imaging-sets-terms-for-%24463-million-IPO

Cardinal Infrastructure Group Inc. (CDNL)

  • Expected listing date: Week of December 8, 2025 (pricing TBA)
  • Price range: $20.00–$22.00 per share
  • Shares offered: 11,500,000 shares (65% synthetic secondary per filings)
  • Exchange: Nasdaq Global Select Market
  • Lead underwriters: Stifel, William Blair
  • Business summary: Southeastern U.S. construction services platform focused on wet utility installations (water, sewer, storm), grading, paving and site development; concentrated in North Carolina growth corridors with a sizable backlog.
  • Notes: Company set terms Dec 1; indicative market cap ~ $769–$805M at range. Timing subject to market conditions and SEC effectiveness.
  • Sources: https://www.reuters.com/business/cardinal-infrastructure-targets-more-than-805-million-valuation-us-ipo-2025-12-01/, https://www.renaissancecapital.com/IPO-Center/News/115239/Construction-services-provider-Cardinal-Infrastructure-sets-terms-for-%24242-

Wealthfront Corporation (WLTH)

  • Expected listing date: Mid‑December 2025 (TBA)
  • Price range: $12.00–$14.00 per share
  • Shares offered: 34,615,384 shares (21,468,038 primary; 13,147,346 secondary) + 5,192,308 overallotment option
  • Exchange: Nasdaq Global Select Market
  • Lead underwriters: Goldman Sachs, J.P. Morgan, Citigroup, Wells Fargo Securities, RBC Capital Markets
  • Business summary: Automated digital wealth platform (robo‑advisory, cash accounts, ETF/bond portfolios, planning tools) targeting mass‑affluent digital natives.
  • Notes: Roadshow launched Dec 2; Reuters reports BlackRock and Wellington indicated interest in up to $150M of shares. Pricing and first trade date TBA, subject to market conditions and SEC effectiveness.
  • Sources: https://www.reuters.com/business/fintech-platform-wealthfront-aims-raise-up-485-million-us-ipo-2025-12-02/, https://www.nasdaq.com/press-release/wealthfront-announces-launch-initial-public-offering-2025-12-02, https://www.prnewswire.com/news-releases/wealthfront-files-registration-statement-for-proposed-initial-public-offering-302570018.html

York Space Systems (YSS)

  • Expected listing date: December 2025 or later (TBA)
  • Exchange: New York Stock Exchange
  • Lead underwriters: Goldman Sachs, Jefferies, Wells Fargo Securities
  • Business summary: Space and defense prime providing design, manufacturing, integration and operation of small satellites (S‑CLASS, LX‑CLASS, M‑CLASS) for national security and commercial missions; major supplier to DoD’s PWSA.
  • Notes: Public S‑1 filed Nov 17; revenue up 59% y/y for 9M25. No terms yet; timing depends on SEC review and market window.
  • Sources: https://www.businesswire.com/news/home/20251114919361/en/York-Space-Systems-Files-Registration-Statement-for-Proposed-Initial-Public-Offering, https://www.reuters.com/business/satellite-provider-york-space-systems-files-us-ipo-2025-11-17/, https://www.renaissancecapital.com/IPO-Center/News/114985/Satellite-manufacturer-York-Space-Systems-files-for-an-estimated-%24400-milli

Klook Technology Limited (ADSs) (KLK)

  • Expected listing date: December 2025 or later (TBA)
  • Exchange: New York Stock Exchange
  • Lead underwriters: Goldman Sachs (Asia) L.L.C., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC
  • Business summary: APAC‑focused online travel experiences marketplace (tours, attractions, transport); SoftBank‑backed; reported 2024 revenue of $417.1M (+24% y/y).
  • Notes: Form F‑1 made public Nov 10; offering size and date not yet set; listing will be via ADSs under KLK, subject to SEC effectiveness and market conditions.
  • Sources: https://www.businesswire.com/news/home/20251109494914/en/Klook-Files-Registration-Statement-for-Proposed-Initial-Public-Offering, https://www.reuters.com/business/travel-booking-platform-klook-makes-us-ipo-filing-public-2025-11-10/

Grayscale Investments, Inc. (GRAY)

  • Expected listing date: Late 2025 or early 2026 (TBA)
  • Exchange: New York Stock Exchange
  • Lead underwriters: Morgan Stanley, BofA Securities, Jefferies, Cantor
  • Business summary: Digital‑asset asset manager known for crypto ETPs/ETFs (e.g., spot bitcoin ETF), managing ~ $30–35B AUM; filed to list Class A common stock.
  • Notes: Public S‑1 filed Nov 13; no terms disclosed. Timeline depends on SEC review and market conditions; could slip into early 2026.
  • Sources: https://www.globenewswire.com/news-release/2025/11/13/3187426/0/en/Grayscale-Investments-Announces-Public-Filing-of-Registration-Statement-for-Proposed-Initial-Public-Offering.html, https://www.reuters.com/business/crypto-focused-grayscale-makes-us-ipo-filing-public-2025-11-13/

Medline Inc. (MDLN)

  • Expected listing date: Potentially December 2025 or early 2026 (TBA)
  • Exchange: Nasdaq Global Select Market
  • Lead underwriters: Goldman Sachs, Morgan Stanley, BofA Securities, J.P. Morgan
  • Business summary: Large manufacturer and distributor of medical‑surgical supplies with extensive U.S. logistics network and private‑label portfolio; LTM revenue ~$32.9B (to 6/28/25).
  • Notes: Public S‑1 announced Oct 28; Renaissance estimates a deal size up to ~$5B, which would be the largest U.S. IPO since 2021. Launch timing uncertain and subject to market conditions.
  • Sources: https://newsroom.medline.com/releases/public-filing-registration-statement-sec/, https://www.renaissancecapital.com/IPO-Center/News/114535/Medical-products-supplier-Medline-files-for-an-estimated-%245-billion-IPO

Timeframe is the next 31 days from Dec 4, 2025. IPO calendars change daily: dates, price ranges, share counts and even issuer participation can shift with markets and SEC review. Entries marked TBA/expected have not set pricing dates and may slip into January 2026. Always confirm with the latest SEC filings, issuer press releases, exchange notices, and deal‑book updates before making decisions.


Sources

  • Stock Ratings: https://finance.yahoo.com/news/tsmc-stock-target-raised-morgan-121223698.html, https://price-target.com/2025/10/29/164190, https://www.ainvest.com/news/broadcom-wells-fargo-maintains-equal-weight-rating-target-price-345-2509/, https://www.businessinsider.com/nvidia-stock-price-prediction-bullish-outlook-ai-chip-revenue-asia-2025-12, https://www.gurufocus.com/news/2971607/jpmorgan-increases-price-target-for-amazon-amzn-to-255--amzn-stock-news, https://www.gurufocus.com/news/3090384/avgo-morgan-stanley-raises-price-target-to-357-while-maintaining-overweight-rating-avgo-stock-news, https://www.gurufocus.com/news/3133898/wells-fargo-raises-meta-platforms-meta-price-target-to-837-meta-stock-news, https://www.gurufocus.com/news/3152412/aapl-wells-fargo-raises-price-target-to-290-maintains-overweight-rating-aapl-stock-news, https://www.gurufocus.com/news/3171027/googl-wells-fargo-raises-alphabets-price-target-to-268-googl-stock-news, https://www.gurufocus.com/news/3172847/googl-morgan-stanley-raises-price-target-amid-overweight-rating-googl-stock-news, https://www.gurufocus.com/news/3172856/msft-sees-price-target-increase-to-690-by-citigroup-maintaining-buy-rating-msft-stock-news, https://www.gurufocus.com/news/3178597/goldman-sachs-raises-price-target-for-nvda-to-240-nvda-stock-news, https://www.gurufocus.com/news/3230110/amazoncom-amzn-wells-fargo-raises-price-target-to-295-amzn-stock-news, https://www.investing.com/news/analyst-ratings/amazon-stock-price-target-raised-to-272-by-bofa-on-strong-retail-growth-93CH-4165296, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-broadcom-stock-price-target-to-400-on-ai-growth-93CH-4226065, https://www.investing.com/news/analyst-ratings/bofa-securities-raises-microsoft-stock-price-target-to-585-on-azure-strength-93CH-4142222, https://www.investing.com/news/analyst-ratings/citi-maintains-apple-stock-buy-rating-with-240-target-amid-iphone-demand-shifts-93CH-4131765, https://www.investing.com/news/analyst-ratings/citi-maintains-buy-rating-and-200-target-on-alphabet-stock-4056278, https://www.investing.com/news/analyst-ratings/citi-maintains-nvidia-stock-buy-rating-163-target-3923024, https://www.investing.com/news/analyst-ratings/citi-raises-amazon-stock-price-target-to-265-on-aws-growth-outlook-4145282, https://www.investing.com/news/analyst-ratings/citi-raises-broadcom-stock-price-target-to-285-on-ai-growth-93CH-4084758, https://www.investing.com/news/analyst-ratings/citi-reiterates-buy-rating-on-meta-stock-maintains-915-price-target-93CH-4244395, https://www.investing.com/news/analyst-ratings/goldman-sachs-initiates-broadcom-stock-with-buy-rating-315-target-93CH-4129499, https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-meta-stock-price-target-to-815-on-investment-cycle-93CH-4317852, https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-500-target-on-microsoft-stock-bullish-on-ai-3887616, https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-buy-rating-on-apple-stock-citing-strong-iphone-17-demand-93CH-4239936, https://www.investing.com/news/analyst-ratings/goldman-sachs-maintains-tesla-stock-at-neutral-with-400-price-target-93CH-4303708, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-alphabet-stock-price-target-to-330-on-strong-cloud-growth-93CH-4317850, https://www.investing.com/news/analyst-ratings/goldman-sachs-raises-nvidia-stock-price-target-to-250-on-ai-outlook-93CH-4369369, https://www.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-amazon-stock-raises-price-target-93CH-4322387, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-alphabet-stock-with-195-target-post-google-io-93CH-4056279, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-apple-stock-rating-with-240-price-target-4077532, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-tesla-stock-underweight-rating-amid-delivery-concerns-4118615, https://www.investing.com/news/analyst-ratings/jpmorgan-maintains-tsmc-stock-overweight-twd1500-target-93CH-3908014, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-broadcom-stock-price-target-to-400-from-325-93CH-4226521, https://www.investing.com/news/analyst-ratings/jpmorgan-raises-microsoft-stock-price-target-to-475-4015871, https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-875-from-795-at-jpmorgan-4163780, https://www.investing.com/news/analyst-ratings/meta-platforms-stock-price-target-raised-to-900-from-775-at-bofa-93CH-4161928, https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-625-from-582-at-morgan-stanley-93CH-4256920, https://www.investing.com/news/analyst-ratings/microsoft-stock-price-target-raised-to-700-from-675-at-wells-fargo-93CH-4318741, https://www.investing.com/news/analyst-ratings/morgan-stanley-lifts-meta-stock-price-target-to-650-4015638, https://www.investing.com/news/analyst-ratings/morgan-stanley-maintains-amazon-stock-overweight-rating-250-target-4018899, https://www.investing.com/news/analyst-ratings/morgan-stanley-maintains-apple-stock-target-amid-app-store-growth-4082375, https://www.investing.com/news/analyst-ratings/morgan-stanley-maintains-tesla-stock-overweight-rating-430-target-93CH-3924182, https://www.investing.com/news/analyst-ratings/tsmc-stock-price-target-raised-to-nt1400-by-citi-on-strong-2q25-results-4140181, https://www.investing.com/news/analyst-ratings/wells-fargo-raises-nvidia-stock-price-target-to-265-on-ai-growth-outlook-93CH-4359275, https://www.investing.com/news/analyst-ratings/wells-fargo-reiterates-underweight-rating-on-tesla-stock-after-eps-miss-93CH-4303537, https://www.investing.com/news/stock-market-news/apple-stock-target-raised-at-bofa-after-new-5year-outlook-analysis-4316591, https://www.investing.com/news/stock-market-news/bofa-raises-tsmc-target-sees-improved-pricing-outlook-4275321, https://www.investing.com/news/stock-market-news/goldman-sachs-boosts-tsmc-pt-to-nt1400-on-ai-growth-outlook-3818781, https://www.marketbeat.com/instant-alerts/alphabet-nasdaqgoogl-price-target-raised-to-33500-2025-10-30/, https://www.marketbeat.com/instant-alerts/nvidia-nasdaqnvda-price-target-raised-to-25000-at-jpmorgan-chase-co-2025-11-20/, https://www.tipranks.com/news/the-fly/tesla-price-target-lowered-to-196-from-224-at-citi
  • IPO Calendar: https://newsroom.medline.com/releases/public-filing-registration-statement-sec/, https://www.businesswire.com/news/home/20251109494914/en/Klook-Files-Registration-Statement-for-Proposed-Initial-Public-Offering, https://www.businesswire.com/news/home/20251114919361/en/York-Space-Systems-Files-Registration-Statement-for-Proposed-Initial-Public-Offering, https://www.globenewswire.com/news-release/2025/11/13/3187426/0/en/Grayscale-Investments-Announces-Public-Filing-of-Registration-Statement-for-Proposed-Initial-Public-Offering.html, https://www.nasdaq.com/press-release/wealthfront-announces-launch-initial-public-offering-2025-12-02, https://www.prnewswire.com/news-releases/lumexa-imaging-announces-launch-of-initial-public-offering-302630316.html, https://www.prnewswire.com/news-releases/wealthfront-files-registration-statement-for-proposed-initial-public-offering-302570018.html, https://www.renaissancecapital.com/IPO-Center/News/114535/Medical-products-supplier-Medline-files-for-an-estimated-%245-billion-IPO, https://www.renaissancecapital.com/IPO-Center/News/114985/Satellite-manufacturer-York-Space-Systems-files-for-an-estimated-%24400-milli, https://www.renaissancecapital.com/IPO-Center/News/115239/Construction-services-provider-Cardinal-Infrastructure-sets-terms-for-%24242-, https://www.renaissancecapital.com/IPO-Center/News/115272/Outpatient-radiology-network-Lumexa-Imaging-sets-terms-for-%24463-million-IPO, https://www.reuters.com/business/cardinal-infrastructure-targets-more-than-805-million-valuation-us-ipo-2025-12-01/, https://www.reuters.com/business/crypto-focused-grayscale-makes-us-ipo-filing-public-2025-11-13/, https://www.reuters.com/business/fintech-platform-wealthfront-aims-raise-up-485-million-us-ipo-2025-12-02/, https://www.reuters.com/business/healthcare-pharmaceuticals/lumexa-imaging-targets-up-189-billion-valuation-us-ipo-2025-12-02/, https://www.reuters.com/business/satellite-provider-york-space-systems-files-us-ipo-2025-11-17/, https://www.reuters.com/business/travel-booking-platform-klook-makes-us-ipo-filing-public-2025-11-10/

Disclaimer

This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.

Generated on: 2025-12-04 at 11:16 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.


Powered by Alpha Signal Monitor | Market Intelligence Through AI

Don't miss what's next. Subscribe to Alpha:
Powered by Buttondown, the easiest way to start and grow your newsletter.